Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1

Ranajoy Chattopadhyay, Soumita Das, Amit K. Maiti, Istvan Boldogh, Jingwu Xie, Tapas Hazra, Kimitoshi Kohno, Sankar Mitra, Kishor K. Bhakat

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Human AP-endonuclease (APE1/Ref-1), a central enzyme involved in the repair of oxidative base damage and DNA strand breaks, has a second activity as a transcriptional regulator that binds to several trans-acting factors. APE1 overexpression is often observed in tumor cells and confers resistance to various anticancer drugs; its downregulation sensitizes tumor cells to such agents. Because the involvement of APE1 in repairing the DNA damage induced by many of these drugs is unlikely, drug resistance may be linked to APE1's transcriptional regulatory function. Here, we show that APE1, preferably in the acetylated form, stably interacts with Y-box-binding protein 1 (YB-1) and enhances its binding to the Y-box element, leading to the activation of the multidrug resistance gene MDR1. The enhanced MDR1 level due to the ectopic expression of wild-type APE1 but not of its nonacetylable mutant underscores the importance of APE1's acetylation in its coactivator function. APE1 downregulation sensitizes MDR1-overexpressing tumor cells to cisplatin or doxorubicin, showing APE1's critical role in YB-1-mediated gene expression and, thus, drug resistance in tumor cells. A systematic increase in both APE1 and MDR1 expression was observed in non-small-cell lung cancer tissue samples. Thus, our study has established the novel role of the acetylation-mediated transcriptional regulatory function of APE1, making it a potential target for the drug sensitization of tumor cells.

Original languageEnglish (US)
Pages (from-to)7066-7080
Number of pages15
JournalMolecular and Cellular Biology
Volume28
Issue number23
DOIs
StatePublished - Dec 2008

Fingerprint

MDR Genes
Neoplasms
Acetylation
Drug Resistance
Y-Box-Binding Protein 1
Down-Regulation
Pharmaceutical Preparations
DNA Breaks
Trans-Activators
Non-Small Cell Lung Carcinoma
Doxorubicin
Cisplatin
DNA Damage
human APEX1 protein
Gene Expression
Enzymes

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. / Chattopadhyay, Ranajoy; Das, Soumita; Maiti, Amit K.; Boldogh, Istvan; Xie, Jingwu; Hazra, Tapas; Kohno, Kimitoshi; Mitra, Sankar; Bhakat, Kishor K.

In: Molecular and Cellular Biology, Vol. 28, No. 23, 12.2008, p. 7066-7080.

Research output: Contribution to journalArticle

Chattopadhyay, Ranajoy ; Das, Soumita ; Maiti, Amit K. ; Boldogh, Istvan ; Xie, Jingwu ; Hazra, Tapas ; Kohno, Kimitoshi ; Mitra, Sankar ; Bhakat, Kishor K. / Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. In: Molecular and Cellular Biology. 2008 ; Vol. 28, No. 23. pp. 7066-7080.
@article{56ae924abd7d4b72b1ff9206f7cfb3f8,
title = "Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1",
abstract = "Human AP-endonuclease (APE1/Ref-1), a central enzyme involved in the repair of oxidative base damage and DNA strand breaks, has a second activity as a transcriptional regulator that binds to several trans-acting factors. APE1 overexpression is often observed in tumor cells and confers resistance to various anticancer drugs; its downregulation sensitizes tumor cells to such agents. Because the involvement of APE1 in repairing the DNA damage induced by many of these drugs is unlikely, drug resistance may be linked to APE1's transcriptional regulatory function. Here, we show that APE1, preferably in the acetylated form, stably interacts with Y-box-binding protein 1 (YB-1) and enhances its binding to the Y-box element, leading to the activation of the multidrug resistance gene MDR1. The enhanced MDR1 level due to the ectopic expression of wild-type APE1 but not of its nonacetylable mutant underscores the importance of APE1's acetylation in its coactivator function. APE1 downregulation sensitizes MDR1-overexpressing tumor cells to cisplatin or doxorubicin, showing APE1's critical role in YB-1-mediated gene expression and, thus, drug resistance in tumor cells. A systematic increase in both APE1 and MDR1 expression was observed in non-small-cell lung cancer tissue samples. Thus, our study has established the novel role of the acetylation-mediated transcriptional regulatory function of APE1, making it a potential target for the drug sensitization of tumor cells.",
author = "Ranajoy Chattopadhyay and Soumita Das and Maiti, {Amit K.} and Istvan Boldogh and Jingwu Xie and Tapas Hazra and Kimitoshi Kohno and Sankar Mitra and Bhakat, {Kishor K.}",
year = "2008",
month = "12",
doi = "10.1128/MCB.00244-08",
language = "English (US)",
volume = "28",
pages = "7066--7080",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1

AU - Chattopadhyay, Ranajoy

AU - Das, Soumita

AU - Maiti, Amit K.

AU - Boldogh, Istvan

AU - Xie, Jingwu

AU - Hazra, Tapas

AU - Kohno, Kimitoshi

AU - Mitra, Sankar

AU - Bhakat, Kishor K.

PY - 2008/12

Y1 - 2008/12

N2 - Human AP-endonuclease (APE1/Ref-1), a central enzyme involved in the repair of oxidative base damage and DNA strand breaks, has a second activity as a transcriptional regulator that binds to several trans-acting factors. APE1 overexpression is often observed in tumor cells and confers resistance to various anticancer drugs; its downregulation sensitizes tumor cells to such agents. Because the involvement of APE1 in repairing the DNA damage induced by many of these drugs is unlikely, drug resistance may be linked to APE1's transcriptional regulatory function. Here, we show that APE1, preferably in the acetylated form, stably interacts with Y-box-binding protein 1 (YB-1) and enhances its binding to the Y-box element, leading to the activation of the multidrug resistance gene MDR1. The enhanced MDR1 level due to the ectopic expression of wild-type APE1 but not of its nonacetylable mutant underscores the importance of APE1's acetylation in its coactivator function. APE1 downregulation sensitizes MDR1-overexpressing tumor cells to cisplatin or doxorubicin, showing APE1's critical role in YB-1-mediated gene expression and, thus, drug resistance in tumor cells. A systematic increase in both APE1 and MDR1 expression was observed in non-small-cell lung cancer tissue samples. Thus, our study has established the novel role of the acetylation-mediated transcriptional regulatory function of APE1, making it a potential target for the drug sensitization of tumor cells.

AB - Human AP-endonuclease (APE1/Ref-1), a central enzyme involved in the repair of oxidative base damage and DNA strand breaks, has a second activity as a transcriptional regulator that binds to several trans-acting factors. APE1 overexpression is often observed in tumor cells and confers resistance to various anticancer drugs; its downregulation sensitizes tumor cells to such agents. Because the involvement of APE1 in repairing the DNA damage induced by many of these drugs is unlikely, drug resistance may be linked to APE1's transcriptional regulatory function. Here, we show that APE1, preferably in the acetylated form, stably interacts with Y-box-binding protein 1 (YB-1) and enhances its binding to the Y-box element, leading to the activation of the multidrug resistance gene MDR1. The enhanced MDR1 level due to the ectopic expression of wild-type APE1 but not of its nonacetylable mutant underscores the importance of APE1's acetylation in its coactivator function. APE1 downregulation sensitizes MDR1-overexpressing tumor cells to cisplatin or doxorubicin, showing APE1's critical role in YB-1-mediated gene expression and, thus, drug resistance in tumor cells. A systematic increase in both APE1 and MDR1 expression was observed in non-small-cell lung cancer tissue samples. Thus, our study has established the novel role of the acetylation-mediated transcriptional regulatory function of APE1, making it a potential target for the drug sensitization of tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=57349170258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349170258&partnerID=8YFLogxK

U2 - 10.1128/MCB.00244-08

DO - 10.1128/MCB.00244-08

M3 - Article

VL - 28

SP - 7066

EP - 7080

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 23

ER -